Drugs Medical Pharma

Eli Lilly gets FDA nod for blood cancer drug

Eli Lilly announced that it had received US FDA approval for a tablet to treat a rare form of blood cancer.

Read More
Health Medical Pharma

Massive spike in Covid-19 deaths over eight weeks: WHO

The Covid-19 virus had claimed the lives of 170,000 people over the last eight weeks, after China lifted restrictions imposed during early stages

Read More
Drugs Health Medical Pharma

WHO draws up new medicine list for nuclear, radiation emergencies

The WHO has updated its list of medicines to stockpile for radiological and nuclear emergencies.

Read More
Drugs Health Pharma

FDA recommends new rules for cannabidiol products

The FDA has suggested new regulations for the use of cannabidiol products, as the existing rules on food and supplements were insufficient for

Read More
Drugs Medical Pharma

Roche unveils test to trace fast-spreading Omicron variant

Roche, a Swiss multinational healthcare company, has unveiled a new test for targeting the fast-spreading XBB.1.5 Omicron sub-variant.

Read More
Drugs Medical Pharma

India’s Bharat Biotech rolls out Covid-19 nasal drop vaccine

Bharat Biotech, an Indian maker of vaccines for infectious diseases, has rolled out the world's first nasal Covid-19 drops as a booster dose,

Read More
Drugs Medical Pharma

Antibiotic shortage forces EU to take measures

A group of European patient and consumer organisations has written a letter to the European Medicines Agency (EMA) expressing concern over the shortage

Read More
Climate Health

Global warming comes knocking on Greenland’s door, glaciologists say

For ten years leading up to 2011, central-north Greenland warmed the most when compared to the past 1,000 years, a study found.

Read More
Drugs Medical Pharma

US health regulator says heart devices recall “most serious”

A recall of Swedish makers' of heart devices has been classified by the FDA as "most serious" since they could lead to severe

Read More
Drugs Pharma

Eli Lilly plans $450 million extra to expand Research Triangle

Eli Lilly will invest an additional $450 million to expand its manufacturing capacity at Research Triangle Park facility in North Carolina.

Read More